Blog
Retatrutide: A Triple-Agonist Breakthrough Transforming Metabolic Research
Retatrutide has captured scientific interest as a next-generation, multi-receptor agonist designed to target the core drivers of metabolic disease. Unlike single-pathway approaches, this engineered peptide engages three key metabolic receptors—GLP‑1, GIP, and glucagon—to influence appetite, glycemic control, and energy expenditure Read more